昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

休市中 08-14 16:08:36

25.080

-0.280

-1.10%

最高25.800	最低24.500	成交量384.88万
今开25.700	昨收25.360	日振幅5.13%
总市值187.85亿	流通市值29.84亿	总股本7.49亿
成交额9,642万	换手率3.23%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":25.08,"timestamp":1786694916006,"preClose":25.36,"halted":0,"volume":3848800,"delay":0,"changeRate":-0.011041009463722443,"floatShares":118995206,"shares":749000000,"eps":0.4,"marketStatus":"休市中","change":-0.28,"latestTime":"08-14 16:08:36","open":25.7,"high":25.8,"low":24.5,"amount":96422120,"amplitude":0.051262,"askPrice":25.08,"askSize":100,"bidPrice":25.06,"bidSize":600,"shortable":3,"etf":0,"ttmEps":0.775955,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":7,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":25.36,"dividendRate":0.005536,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.36779963505475155,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":51.3,"timestamp":1786690800000,"preClose":51.9,"halted":0,"volume":39913100,"delay":0,"premium":"-57.98"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2658753589","title":"昭衍新药：低价订单正在有序出清","url":"https://stock-news.laohu8.com/highlight/detail?id=2658753589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658753589?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:39","pubTimestamp":1786527545,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药08月12日在投资者关系平台上答复投资者关心的问题。低价订单方面，自 2025 年四季度行业回暖、新单量价修复以来，前期存量低价订单正在有序出清。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","06127","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978431","title":"昭衍新药：截至2026年一季度末在手订单金额为31亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978431","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658978431?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:57","pubTimestamp":1786525037,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药(603127)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问贵公司在手订单、项目排期情况如何？实验动物相关价格和订单如何？昭衍新药回复：您好！截至 2026 年一季度末，公司在手订单金额为 31 亿元人民币。伴随生物医药行业需求企稳回暖，现有订单形成一定的交付排期，叠加行业景气度修复，非人灵长类实验动物价格和订单签约价格相较前期都有所回升。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200028146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK1141","MUCmain","CNHmain","UCmain","BK1576","BK0216","CYB","MCNHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609113","title":"医药外包概念股集体扬升 药明生物（02269）涨4.36% 机构指行业景气度上行信号明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609113","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609113?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:58","pubTimestamp":1786327110,"startTime":"0","endTime":"0","summary":"消息面上，国金证券发布研报指，CXO行业已完整经历一轮产业周期，当下行业景气度上行信号明确。目前，随着外部压力缓释、全球投融资回暖，国内BD持续升温，行业已进入内外需共振、新分子赛道放量、订单与业绩逐季改善的新一轮复苏上行周期。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987777","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","06821","HK0000306701.USD","LU0052750758.USD","159938","LU0181495838.USD","LU0588546209.SGD","02359","LU0320764599.SGD","LU2039709279.SGD","LU3063872942.SGD","BK1521","LU0456827905.SGD","LU1880383366.USD","LU0516422366.SGD","LU0140636845.USD","LU1242518857.USD","HK0000320264.USD","IE00B0JY6N72.USD","LU0708995583.HKD","LU2242644610.SGD","BK1141","02269","LU2125910500.SGD","LU0417516738.SGD","BK1589","LU0348767384.USD","09939","BK1576","BK1515","LU0043850808.USD","LU0823426480.USD","LU0979878070.USD","LU1046422090.SGD","BK1574","BK1161","06127","LU0051755006.USD","LU0516423174.USD","LU0572944931.SGD","LU1242518931.SGD","LU0307460666.USD","KURE","LU0823426308.USD","LU1720050803.USD","SG9999002562.SGD","01521","LU0819121731.USD","BK1191","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108825068","title":"异动解读｜昭衍新药盘中上涨5.24%，CXO板块延续强势带动临床前CRO龙头续涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1108825068","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108825068?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:47","pubTimestamp":1786326445,"startTime":"0","endTime":"0","summary":"8月10日，昭衍新药盘中上涨5.24%，报28.92港元，成交额1.35亿港元。消息面上，生命科学工具和服务板块延续强势，药明康德涨4.21%、药明生物涨4.88%、金斯瑞生物科技涨5.48%，板块全线走强。此前药明康德披露半年报，上半年营收288.97亿元同比增长38.93%，扣非净利润同比增长89.39%，并上调全年业绩指引，持续提振CXO板块情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658735466","title":"每周股票复盘：昭衍新药（603127）A股限制性股票激励计划完成授予","url":"https://stock-news.laohu8.com/highlight/detail?id=2658735466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658735466?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:05","pubTimestamp":1786208712,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，昭衍新药报收于50.89元，较上周的41.54元上涨22.51%。本周关注点公司公告汇总：2026年A股限制性股票激励计划于7月22日完成授予，A股已发行股份增加2,636,300股。公司公告汇总H股公告：7月月报表北京昭衍新药研究中心股份有限公司截至2026年7月31日的证券变动月报表显示，H股和A股的法定注册资本无变动。本月底已发行A股总数为630,353,014股，其中库存股为537,620股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","399300","603127","BK0216","BK1576","06127","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657961579","title":"8月7日昭衍新药涨10.01%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657961579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657961579?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:37","pubTimestamp":1786091852,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日昭衍新药涨10.01%，收盘报50.89元，换手率9.48%，成交量59.53万手，成交额28.88亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.8412，较上一交易日下跌0.3%，近一年下跌11.34%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1141","BK1576","06127","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615881","title":"智通AH统计|8月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615881","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657615881?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:15","pubTimestamp":1786090505,"startTime":"0","endTime":"0","summary":"东北电气0.2442.251006.56%71.67%浙江世宝3.93015.44370.48%22.80%中石化油服0.6452.21310.85%-6.08%弘业期货2.2357.51302.68%8.61%复旦张江2.5407.9272.44%-0.39%龙源电力5.49015.96248.27%-10.25%南京熊猫电子股份3.4409.94246.22%10.73%凯盛新能2.4056.93245.11%-1.50%晨鸣纸业0.6701.9240.30%-24.37%安德利果汁22.86064.81239.59%-64.68%. 安德利果汁22.86064.81239.59%-64.68%晨鸣纸业0.6701.9240.30%-24.37%龙蟠科技10.21019.48128.50%-22.72%蓝思科技22.10035.994.57%-21.62%大唐发电2.4756.29204.24%-21.13%金风科技11.55021.8126.06%-18.52%昭衍新药27.50050.89121.67%-18.31%立讯精密63.35056.997.75%-14.58%中国银河7.72012.4192.49%-13.23%中兴通讯24.70034.6968.22%-13.07%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01688","01276","00300","01033","01057","00916","06127","HPAD.SI","01108","03308","BK1240","00763","03145","PNGAY","06745","00956","EWH","LU1831875114.USD","IE00BZ08YR35.GBP","01349","02218","03200","06881","02359","00042","00598","03143","02318","02338","00568","LU0029875118.USD","03750","399300","02768","159982","06655","02208","02475","06613","03968","00553","03678","03986","PAImain","82318","601318","01812","02465","00991"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657818618","title":"港股异动 | 昭衍新药(06127)涨超11% 公司上半年业绩大幅预增 生物资产公允价值正向变动成为核心驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2657818618","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657818618?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:20","pubTimestamp":1786087248,"startTime":"0","endTime":"0","summary":"消息面上，近期，昭衍新药发布2026半年度业绩预告，中邮证券指出，2026年上半年，公司预计实现营业收入约6.69亿元至7.39亿元，实现归母净利润约6.00亿元至9.00亿元，实现扣非归母净利润约5.61亿元至8.42亿元。中邮证券认为，生物资产公允价值正向变动成为昭衍新药本期业绩爆发的核心驱动力。2026H1公司生物资产公允价值变动贡献的净利润约7.03亿元至7.77亿元，较2025年同期的0.88亿元大幅提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1141","BK4585","BK4588","VXUS","06127","BK1576","603127","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657361881","title":"港股异动 | 昭衍新药(06127.HK)涨超11% 公司上半年业绩大幅预增 生物资产公允价值正向变动成为核心驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2657361881","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657361881?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:20","pubTimestamp":1786087248,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06127","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657589694","title":"异动快报：昭衍新药（603127）8月7日14点7分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2657589694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657589694?lang=zh_cn&edition=full","pubTime":"2026-08-07 14:10","pubTimestamp":1786083046,"startTime":"0","endTime":"0","summary":"证券之星8月7日盘中消息，14点7分昭衍新药（603127）触及涨停板。其所属行业医疗服务目前上涨。领涨股为博腾股份。该股为基因编辑，CAR-T疗法，创新药概念热股，当日基因编辑概念上涨6.16%，CAR-T疗法概念上涨5.68%，创新药概念上涨5.52%。8月6日的资金流向数据方面，主力资金净流入4704.0万元，占总成交额2.34%，游资资金净流出8636.49万元，占总成交额4.29%，散户资金净流入3932.48万元，占总成交额1.95%。近5日资金流向一览见下表：昭衍新药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700020312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","06127","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160477648","title":"异动解读｜昭衍新药盘中上涨5.63%，CXO板块持续走强带动临床前CRO龙头反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1160477648","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160477648?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:57","pubTimestamp":1786071447,"startTime":"0","endTime":"0","summary":"8月7日，昭衍新药（06127.HK）盘中上涨5.63%，报25.9港元，成交额1.08亿港元。消息面上，生命科学工具和服务板块延续强势，康龙化成涨9.46%、药明合联涨7.94%、药明生物涨6.14%、药明康德涨5.84%，板块全线走强。此前药明康德披露半年报，上半年营收288.97亿元同比增长38.93%，扣非净利润同比增长89.39%，并全面上调全年业绩指引，持续提振CXO板块情绪。叠加行业多家头部企业一季度新签订单大幅增长，CRO/CDMO行业订单回暖趋势延续，带动板块联动上行。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药盘中上涨5.63%，CXO板块持续走强带动临床前CRO龙头反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657281645","title":"昭衍新药（603127）披露2026年A股限制性股票激励计划授予完成情况，8月5日股价上涨4.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657281645","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657281645?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:04","pubTimestamp":1785938665,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，昭衍新药报收于46.3元，较前一交易日上涨4.4%，最新总市值为346.95亿元。近日，公司披露H股公告《7月月报表》。公告显示，北京昭衍新药研究中心股份有限公司截至2026年7月31日的证券变动月报表显示，H股和A股的法定注册资本无变动。A股已发行股份因2026年A股限制性股票激励计划于2026年7月22日授予，导致已发行股份增加2,636,300股，库存股相应减少2,636,300股。本月底已发行A股总数为630,353,014股，其中库存股为537,620股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","399300","BK0216","BK1141","06127","159982","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134877434","title":"昭衍新药发布2026年7月股份变动月报，H股维持不变A股授予限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1134877434","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134877434?lang=zh_cn&edition=full","pubTime":"2026-08-05 15:32","pubTimestamp":1785915163,"startTime":"0","endTime":"0","summary":"2026年8月5日，北京昭衍新药研究中心股份有限公司公布2026年7月股份变动月报，报告期截至2026年7月31日。根据公告，昭衍新药本期H股无新增发行或库存变动，A股因限制性股票激励计划完成授予动作，导致公司A股已发行股份与库存股之间的数量发生相应变动。公告显示，H股股本数量本期保持在118,995,206股，库存股为0股，合计保持不变。上述变动主要源自2026年A股限制性股票激励计划，在2026年7月22日依据相关股东大会决议完成2,636,300股A股授予。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656365725","title":"8月4日昭衍新药涨8.04%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656365725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656365725?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:35","pubTimestamp":1785832545,"startTime":"0","endTime":"0","summary":"证券之星消息，8月4日昭衍新药涨8.04%，收盘报44.35元，换手率9.81%，成交量61.56万手，成交额26.96亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为35.24亿元，最新净值1.7486，较上一交易日下跌2.18%，近一年下跌16.94%。广发医疗保健股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603127","BK0216","BK1576","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128561097","title":"异动解读｜昭衍新药盘中上涨5.46%，生命科学工具板块全线走强带动CRO龙头反弹","url":"https://stock-news.laohu8.com/highlight/detail?id=1128561097","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128561097?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:39","pubTimestamp":1785807598,"startTime":"0","endTime":"0","summary":"8月4日，昭衍新药（06127.HK）盘中上涨5.46%，报23.92港元，成交额3981.88万港元。消息面上，生命科学工具和服务板块全线大幅走强，药明康德涨13.2%、康龙化成涨8.63%、金斯瑞生物科技涨7.61%、药明合联涨6.33%、药明生物涨5.26%，板块个股普遍录得显著涨幅。此前CRO行业多家头部企业一季度新签订单实现大幅增长，行业订单全面回暖趋势延续，叠加公司此前确认非人灵长类实验动物供需呈紧张状态、价格较前期有所增长，基本面支撑下板块联动效应显著。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药盘中上涨5.46%，生命科学工具板块全线走强带动CRO龙头反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656863415","title":"药明康德（02359）中期业绩提振医药外包概念股 凯莱英（06821）涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656863415","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656863415?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:36","pubTimestamp":1785807412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德 中期业绩强劲，推动股价大涨逾14%，同步提振医药外包概念股，凯莱英涨7.98%，康龙化成涨7.58%，泰格医药涨5.62%，金斯瑞生物科技涨6.01%，药明生物涨4.95%，昭衍新药涨4.93%，维亚生物涨1.96%。据药明康德公告，上半年公司实现营业收入288.97亿元，同比增长38.93%；归属于上市公司股东的净利润110.8亿元，同比增长29.43%；扣非净利润105.72亿元，同比增长89.39%。公司计划上半年向全体股东每10股派发现金红利5.10元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987415","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456842615.SGD","BK0239","LU0700851271.USD","BK1589","BK1583","02359","LU0823426308.USD","LU1808992512.USD","02269","LU0856984785.SGD","LU0039217434.USD","LU1688375341.USD","LU2488822045.USD","LU0181495838.USD","IE00B5MMRT66.SGD","LU0611395673.USD","LU0348767384.USD","06127","BK1576","SG9999002562.SGD","LU1251922891.USD","HK0000320223.HKD","LU2242644610.SGD","06821","LU0307460666.USD","LU0320764599.SGD","HK0000306685.HKD","LU0348766576.USD","KURE","LU0359202008.SGD","LU1046422090.SGD","BK1610","01873","LU1303224171.USD","09939","01548","HK0000320264.USD","002821","603259","BK1191","03759","BK1515","LU0979878070.USD","LU0516422440.USD","LU1997245094.SGD","159938","IE00BPRC5H50.USD","LU2045819591.USD","03347","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656816586","title":"港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656816586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656816586?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:34","pubTimestamp":1785807258,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月4日，恒生指数高开0.31%，报26090.98点；恒生科技指数涨0.30%，报4890.34点。医药CXO板块大幅走强，药明康德涨近10%，药明生物涨超3%，昭衍新药涨近6%，凯莱英涨超5%，泰格医药涨近4%。药明康德此前披露半年报，上半年营收288.97亿元同比增长38.93%，并全面上调全年业绩指引。光通信板块活跃，中际旭创涨超9%。云计算及AI应用板块走高，金山云涨超5%。受隔夜美股科技板块走强带动，港股今日延续高开。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823426480.USD","LU0348767384.USD","SG9999002562.SGD","LU0417516738.SGD","LU0516422440.USD","07500","03088","03423","BK1576","300308","LU1242518857.USD","LU1794554557.SGD","603259","MCHmain","LU1046422090.SGD","LU0588546209.SGD","83115","LU0823426308.USD","LU0819121731.USD","LU0516422366.SGD","BK1122","BK1149","02800","LU0456827905.SGD","BK1589","LU0348825331.USD","LU0326950275.SGD","LU0856984785.SGD","03347","BK1141","03032","09115","LU0140636845.USD","LU0181495838.USD","LU0417516902.SGD","300347","82800","LU0516423091.SGD","LU0572944931.SGD","LU0320764599.SGD","WXXWY","IE00B0JY6N72.USD","SG9999002463.SGD","HSI","07552","LU1880383366.USD","LU2125910500.SGD","06821","513600","LU0359202008.SGD","03033","603127","07226","03067","LU0307460666.USD","09067","BK1533","LU2242644610.SGD","LU2039709279.SGD","07300","LU0359201612.USD","LU3063872942.SGD","BK1191","BK1249","02359","03417","07200","BK1610","02837","LU2045819591.USD","LU0052750758.USD","LU0051755006.USD","LU0456846285.SGD","LU0043850808.USD","06127","BK1583","02269","03419","LU0327786744.USD","03037","HHImain","LU1688375341.USD","KURE","LU0348735423.USD","LU0708995583.HKD","LU0979878070.USD","LU0348766576.USD","LU0516423174.USD","BK1521","LU0516422952.EUR","HSTECH","LU0039217434.USD","LU1242518931.SGD","02833","002821","LU1720050803.USD","03115","03308","09088"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656321656","title":"智通AH统计|8月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2656321656","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656321656?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:15","pubTimestamp":1785744913,"startTime":"0","endTime":"0","summary":"东北电气0.2482.25988.71%67.73%浙江世宝3.94014.74348.22%-2.00%中石化油服0.6402.26323.44%6.23%弘业期货2.2807.77308.33%19.81%复旦张江2.4207.32262.40%-11.30%晨鸣纸业0.6701.99255.22%-12.00%凯盛新能2.4507.06245.31%-6.48%龙源电力5.73516.5244.55%-17.15%南京熊猫电子股份3.4059.75243.02%5.74%京城机电股份3.0208.3229.14%7.67%. 东北电气0.2482.25988.71%67.73%国恩科技32.08050.990.06%33.12%大族数控90.050227.18202.19%25.40%长飞光纤光缆95.700260.68226.27%20.14%弘业期货2.2807.77308.33%19.81%大众公用2.4054.87142.41%17.69%东江环保1.6703.53153.29%16.94%华新建材14.11021.9386.18%15.95%广和通7.75020.57217.94%14.86%领益智造6.36012.43134.12%14.18%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02691","LU0588545730.USD","02768","06680","01276","IE00BVYPNQ40.USD","03678","03750","01057","159982","01108","01635","00187","00638","00916","02208","03328","06655","00553","01688","02338","03143","06127","00300","02465","02715","601318","PNGAY","03986","06613","EWH","399300","00991","03968","01033","03145","00042","00763","01349","03308","03200","06869","02359","00895","02318","HPAD.SI","PAImain","01812","82318"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655333030","title":"医药外包概念整体回暖 昭衍新药（06127）涨4.51%、康龙化成（03759）涨3.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655333030","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655333030?lang=zh_cn&edition=full","pubTime":"2026-07-31 10:18","pubTimestamp":1785464310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念整体回暖，截止发稿，昭衍新药 涨4.51%，康龙化成涨3.10%，金斯瑞生物科技涨2.97%，凯莱英涨2.77%，药明生物涨2.75%，药明康德涨2.60%，泰格医药涨1.39%。26年至今国内创新药行业的长期结构性机会持续兑现，国内投融资持续改善，新药物形式赛道持续火热并进一步放量，该机构认为26年国内CRO/CDMO行业的新签订单及业绩会加速增长，带动CXO产业链进入新一轮发展阶段。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987205","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","09939","LU0359202008.SGD","LU0708995583.HKD","LU0516423091.SGD","HK0000306685.HKD","LU0359201612.USD","LU0823426480.USD","LU0051755006.USD","LU2045819591.USD","06127","LU3063872942.SGD","HK0000306701.USD","BK1589","SG9999002463.SGD","03347","BK1521","LU0140636845.USD","LU0307460666.USD","LU1242518931.SGD","06821","01548","LU0348766576.USD","LU0456827905.SGD","LU0348825331.USD","02269","LU0516422366.SGD","02359","LU1880383366.USD","300759","BK1141","LU1794554557.SGD","BK1191","LU1720050803.USD","LU0320764599.SGD","LU0819121731.USD","603127","LU0348735423.USD","LU0516422440.USD","LU1242518857.USD","159938","LU0181495838.USD","LU0588546209.SGD","LU0823426308.USD","03759","LU0417516738.SGD","BK1610","LU1046422090.SGD","KURE","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177565254","title":"异动解读｜昭衍新药盘中上涨5.95%，生命科学板块全线走强叠加实验猴供需紧张确认","url":"https://stock-news.laohu8.com/highlight/detail?id=1177565254","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177565254?lang=zh_cn&edition=full","pubTime":"2026-07-31 10:02","pubTimestamp":1785463331,"startTime":"0","endTime":"0","summary":"7月31日，昭衍新药（06127.HK）盘中上涨5.95%，报23.1港元，成交额4810.32万港元。消息面上，生命科学工具和服务板块全线走强，英矽智能涨7.42%、晶泰控股涨2.79%、金斯瑞生物科技涨2.79%、药明康德涨2.03%、药明生物涨1.9%，行业个股普遍反弹。此外，公司近日在投资者互动平台确认，国内创新药融资及BD交易持续回暖带动行业需求增长，叠加供给弹性较低，非人灵长类实验动物供需呈紧张状态，价格较前期有所增长。前两个交易日股价累计回调逾15%后，短线超跌修复动能释放。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药盘中上涨5.95%，生命科学板块全线走强叠加实验猴供需紧张确认","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.088},{"period":"1month","weight":-0.0873},{"period":"3month","weight":0.2319},{"period":"6month","weight":0.1715},{"period":"1year","weight":0.0293},{"period":"ytd","weight":0.2272}],"compareEarnings":[{"period":"1week","weight":-0.0215},{"period":"1month","weight":0.0177},{"period":"3month","weight":-0.0326},{"period":"6month","weight":-0.0546},{"period":"1year","weight":-0.0158},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052852},{"month":2,"riseRate":0.6,"avgChangeRate":0.086368},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020373},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07562},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065576},{"month":6,"riseRate":0.666667,"avgChangeRate":0.063039},{"month":7,"riseRate":0.833333,"avgChangeRate":0.119134},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.105315},{"month":9,"riseRate":0.6,"avgChangeRate":0.01621},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062964},{"month":11,"riseRate":0.4,"avgChangeRate":0.019565},{"month":12,"riseRate":0.6,"avgChangeRate":0.001933}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}